Trial Profile
Phase I Study To Determine The Safety Of Caelyx (Doxorubin HCI, Pegylated Liposomal) In Combination With Ifosfamide In Previously Untreated Adult Patients With Advanced And/Or Metastatic Soft Tissues Sarcomas.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Oct 2012
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Ifosfamide (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 29 Sep 2005 New trial record.